CLINICAL_TRIALS
trial_result
· 2020-04-02
Clinical Trial Update: TOFAcitinib in SARS-CoV2 Pneumonia [Phase 2]
Summary
Phase 2 trial update for tofacitinib in SARS-CoV-2 related interstitial pneumonia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Università Politecnica delle Marche | Conditions: SARS-COv2 Related Interstitial Pneumonia | Phase 2 | Status: UNKNOWN